Pharma | IIPRD

Compulsory Licensing Application against the Patented Drug SAXAGLIPTIN by Lee Pharma

July 27, 2015
India, IP Practice in India, News & Updates, Patents, Pharma

Lee Pharma, a Hyderabad based Indian pharma company, has filed a Compulsory Licensing (CL) Application (in accordance with Section 84(1) of the Indian Patents Act) against one of the patented drug Saxagliptin for treating Diabetes Mellitus. The Patent on Saxagliptin…

News Snippet: Novartis sues Cipla for infringement of patents covering “Onbrez”

December 22, 2014
India, IP Litigation, IP Practice in India, News & Updates, patent infringement, Patents, Pharma

In the latest update, Novartis has sued Cipla for infringing its patents on “Onbrez” (Indacaterol) after Cipla launched its generic version for Indacaterol in October claiming “urgent unmet need” for the drug in India. Earlier, as we have reported here,…

Previous
Page 1
Page 2
Page 3
Page 4

Kindly complete the form to download the report